vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and VINCE HOLDING CORP. (VNCE). Click either name above to swap in a different company.
VINCE HOLDING CORP. is the larger business by last-quarter revenue ($85.1M vs $44.9M, roughly 1.9× AbCellera Biologics Inc.). VINCE HOLDING CORP. runs the higher net margin — 3.2% vs -19.9%, a 23.1% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 6.2%). VINCE HOLDING CORP. produced more free cash flow last quarter ($-5.7M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 6.3%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
VINCE. is a contemporary clothing fashion brand founded in 2002. In 2023 Authentic Brands Group purchased its intellectual property in a $76.5 million deal.
ABCL vs VNCE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $85.1M |
| Net Profit | $-8.9M | $2.7M |
| Gross Margin | — | 49.2% |
| Operating Margin | -63.7% | 6.4% |
| Net Margin | -19.9% | 3.2% |
| Revenue YoY | 788.4% | 6.2% |
| Net Profit YoY | 73.9% | -37.3% |
| EPS (diluted) | $-0.03 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $85.1M | ||
| Q3 25 | $9.0M | $73.2M | ||
| Q2 25 | $17.1M | $57.9M | ||
| Q1 25 | $4.2M | $80.0M | ||
| Q4 24 | $5.0M | $80.2M | ||
| Q3 24 | $6.5M | $74.2M | ||
| Q2 24 | $7.3M | $59.2M | ||
| Q1 24 | $10.0M | $75.3M |
| Q4 25 | $-8.9M | $2.7M | ||
| Q3 25 | $-57.1M | $12.1M | ||
| Q2 25 | $-34.7M | $-4.8M | ||
| Q1 25 | $-45.6M | $-28.3M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | $-51.1M | $569.0K | ||
| Q2 24 | $-36.9M | $4.4M | ||
| Q1 24 | $-40.6M | $-4.7M |
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 50.4% | ||
| Q2 25 | — | 50.3% | ||
| Q1 25 | — | 50.1% | ||
| Q4 24 | — | 50.0% | ||
| Q3 24 | — | 47.4% | ||
| Q2 24 | — | 50.6% | ||
| Q1 24 | — | 45.4% |
| Q4 25 | -63.7% | 6.4% | ||
| Q3 25 | -851.8% | 15.2% | ||
| Q2 25 | -290.2% | -7.7% | ||
| Q1 25 | -1479.6% | -37.1% | ||
| Q4 24 | — | 7.2% | ||
| Q3 24 | -1439.4% | 1.5% | ||
| Q2 24 | -1276.2% | 9.5% | ||
| Q1 24 | -551.5% | -2.2% |
| Q4 25 | -19.9% | 3.2% | ||
| Q3 25 | -637.8% | 16.5% | ||
| Q2 25 | -203.3% | -8.3% | ||
| Q1 25 | -1077.2% | -35.5% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | -785.4% | 0.8% | ||
| Q2 24 | -504.3% | 7.4% | ||
| Q1 24 | -408.0% | -6.2% |
| Q4 25 | $-0.03 | $0.21 | ||
| Q3 25 | $-0.19 | $0.93 | ||
| Q2 25 | $-0.12 | $-0.37 | ||
| Q1 25 | $-0.15 | $-2.25 | ||
| Q4 24 | — | $0.34 | ||
| Q3 24 | $-0.17 | $0.05 | ||
| Q2 24 | $-0.13 | $0.35 | ||
| Q1 24 | $-0.14 | $-0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $1.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $53.4M |
| Total Assets | $1.4B | $246.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $1.1M | ||
| Q3 25 | $83.2M | $777.0K | ||
| Q2 25 | $92.4M | $2.6M | ||
| Q1 25 | $159.3M | $607.0K | ||
| Q4 24 | $156.3M | $892.0K | ||
| Q3 24 | $126.6M | $711.0K | ||
| Q2 24 | $148.3M | $739.0K | ||
| Q1 24 | $123.6M | $357.0K |
| Q4 25 | $966.9M | $53.4M | ||
| Q3 25 | $964.0M | $49.3M | ||
| Q2 25 | $1.0B | $37.2M | ||
| Q1 25 | $1.0B | $41.8M | ||
| Q4 24 | $1.1B | $57.1M | ||
| Q3 24 | $1.1B | $52.4M | ||
| Q2 24 | $1.1B | $51.7M | ||
| Q1 24 | $1.1B | $47.2M |
| Q4 25 | $1.4B | $246.0M | ||
| Q3 25 | $1.4B | $239.0M | ||
| Q2 25 | $1.4B | $218.0M | ||
| Q1 25 | $1.3B | $222.7M | ||
| Q4 24 | $1.4B | $254.7M | ||
| Q3 24 | $1.4B | $253.6M | ||
| Q2 24 | $1.4B | $223.1M | ||
| Q1 24 | $1.5B | $225.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $-5.1M |
| Free Cash FlowOCF − Capex | $-44.6M | $-5.7M |
| FCF MarginFCF / Revenue | -99.4% | -6.7% |
| Capex IntensityCapex / Revenue | 21.9% | 0.7% |
| Cash ConversionOCF / Net Profit | — | -1.86× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $4.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $-5.1M | ||
| Q3 25 | $-52.6M | $4.2M | ||
| Q2 25 | $-32.4M | $-11.8M | ||
| Q1 25 | $-11.6M | $22.7M | ||
| Q4 24 | $-108.6M | $6.4M | ||
| Q3 24 | $-28.9M | $-3.2M | ||
| Q2 24 | $-30.0M | $-3.9M | ||
| Q1 24 | $-41.7M | $14.8M |
| Q4 25 | $-44.6M | $-5.7M | ||
| Q3 25 | $-61.5M | $2.1M | ||
| Q2 25 | $-45.8M | $-13.2M | ||
| Q1 25 | $-22.2M | $21.2M | ||
| Q4 24 | $-187.0M | $5.1M | ||
| Q3 24 | $-47.4M | $-3.9M | ||
| Q2 24 | $-50.1M | $-4.6M | ||
| Q1 24 | $-65.8M | $14.2M |
| Q4 25 | -99.4% | -6.7% | ||
| Q3 25 | -687.0% | 2.9% | ||
| Q2 25 | -267.9% | -22.9% | ||
| Q1 25 | -524.0% | 26.5% | ||
| Q4 24 | -3702.8% | 6.4% | ||
| Q3 24 | -728.4% | -5.2% | ||
| Q2 24 | -683.8% | -7.8% | ||
| Q1 24 | -661.5% | 18.9% |
| Q4 25 | 21.9% | 0.7% | ||
| Q3 25 | 99.7% | 2.9% | ||
| Q2 25 | 78.2% | 2.5% | ||
| Q1 25 | 251.1% | 1.9% | ||
| Q4 24 | 1552.7% | 1.6% | ||
| Q3 24 | 284.6% | 0.9% | ||
| Q2 24 | 274.6% | 1.3% | ||
| Q1 24 | 242.5% | 0.7% |
| Q4 25 | — | -1.86× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.48× | ||
| Q3 24 | — | -5.61× | ||
| Q2 24 | — | -0.89× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
VNCE
| Vince Wholesale | $52.0M | 61% |
| Vince Direct To Consumer | $33.1M | 39% |
